Health and Medicine Photo credit:
dreamerb/Shutterstock
In an attempt to battle the 2009 swine flu pandemic, two separate pharmaceutical companies developed vaccines for the causative H1N1 strain: Pandemrix, produced by GlaxoSmithKline (GSK), and Focetria, created by Novartis. But the former left GSK with their own battle – with its dissemination came a peculiar rise in cases of narcolepsy, a chronic and incurable brain disorder that disrupts sleep-wake cycles.
Published on July 05, 2015 14:00